Loading...
•
Dec 29, 2023
STAAR Surgical Q4 2023 Earnings Report
STAAR Surgical experienced double-digit sales growth and maintained profitability.
Key Takeaways
STAAR Surgical reported a 19% increase in net sales to $76.3 million for the fourth quarter of 2023, driven by a 22% increase in ICL sales. Net income increased to $7.8 million, or $0.16 per share. The company affirmed its fiscal year 2024 net sales outlook of $335 million to $340 million.
Net sales increased by 19% to $76.3 million in Q4.
ICL sales grew by 22% to $74.6 million, with a 19% increase in ICL units.
Gross margin was 79.6% compared to 77.7% in the prior year.
Net income reached $7.8 million, resulting in earnings per share of $0.16.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company expects net sales of $335 million to $340 million for fiscal year 2024.
Positive Outlook
- EVO ICL sales growth of approximately 7% in APAC, including 10% in China.
- 10% growth in the Americas, including 10% in the U.S.
- EMEA sales consistent with fiscal year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...